Channels - A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata :: FRELIP Discovery

Similar Items: A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata

Quick Look
Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
Quick Look
A Theoretical Model for the Treatment of Androgenetic Alopecia Using the STEAP3 Protein, and the Genetic Challenges of Treating AGA
Quick Look
The Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia
Quick Look
Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis Pigmentosa
Quick Look
Public Health Impact and Cost-Effectiveness of 2-Dose vs 1-Dose Human Papillomavirus Vaccination Regimen in Saudi Arabia
Quick Look
Real-World Ritlecitinib Treatment of Severe Alopecia Areata in the United States: Patient Characteristics and Physician Satisfaction According to a Secondary Database Analysis
Quick Look
Beliefs about race differences in pain vs. actual race differences in pain: An experimental investigation.
Quick Look
Drug use vs. abstinence after incarceration: associations with competing psychosocial needs and their relevance to the importance of treatment
Quick Look
Understanding Barriers to Effective Injury Care by Medical Trainees and Traffic Law Enforcement First Responders in Low-Income Contexts in Uganda (Motor Registry Project Part 2): Convergent Mixed Methods Analysis
Quick Look
Cognitive Behavioral Therapy in Early Intervention for Psychosis: A Cost-Effectiveness Analysis
Quick Look
Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy
Quick Look
Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective
Quick Look
Prevalence, Clinical Profiles, Disease Severity, and Patient Outcomes of Alcoholic Liver Disease in a Tertiary Care Hospital of Nepal
Quick Look
Value of Blood Count–Derived Inflammatory Markers for Evaluating Psoriasis Severity: Pilot Cross-Sectional Observational Study
Quick Look
A Cost Analysis of Adverse Event Management of Systemic Therapies for Metastatic Colorectal Cancer on Patients with at Least Two Previous Lines of Treatment in Spain
Quick Look
Nivolumab-AVD versus Brentuximab Vedotin-AVD as First-Line Treatment for Advanced-Stage Classical Hodgkin Lymphoma: A Cost-Effectiveness Analysis
Quick Look
COVID-19 Severity Among American Indians and Alaska Natives in 16 States - January 1, 2020, to March 31, 2021
Quick Look
Cost Minimization and Cost Comparison of the Use of Conventional Double Lumen Tube versus Single-Use VivaSight-Double Lumen Tube in Thoracic Surgery: The Pascale Institute Experience
Quick Look
Social Impact and Economic Burden of Uncoded Hyponatremia in Elderly – A Cost-of-Illness Study
Quick Look
Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early Preterm Birth in Australia Compared with Current Practice
Quick Look
Prevalence, Severity, and Sociodemographic Correlates of Depression and Post-Traumatic Stress Disorder among Internally Displaced Women Affected by the Boko Haram Insurgency in Maiduguri, Nigeria
Quick Look
Healthcare Resource Utilization and the Direct Medical Cost of Fibromyalgia Patients in a Tertiary Hospital in Saudi Arabia
Quick Look
Discounting Practices in Cost-Effectiveness Analyses in Dentistry: A Systematic Review of Studies Published After 2020
Quick Look
Cost-Effectiveness and Clinical Utility of Pancreatic Cancer Non-Invasive Test in New-Onset Diabetes